Diseases, Conditions, Syndromes

Hydroxyurea underused in youth with sickle cell

Few youths with sickle cell anemia (SCA) receive hydroxyurea despite national guidelines recommending its use, according to a study published online March 24 in JAMA Network Open.

Oncology & Cancer

Studying the impact of stem cell transplants

People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.

page 10 from 40